Annotations
Disease Ontology
disease of cellular proliferation (DOID:14566)
A disease that is characterized by abnormally rapid cell division.
Table Filters
- Lipids measured in liver metastasis from breast cancer - WP4627 (Mus musculus)
- 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression - WP3879 (Homo sapiens)
- Acute myeloid leukemia - WP5293 (Homo sapiens)
- Aflatoxin B1 metabolism - WP699 (Homo sapiens)
- Altered glycosylation of MUC1 in tumor microenvironment - WP4480 (Homo sapiens)
- Amino acid metabolism in triple-negative breast cancer cells - WP5213 (Homo sapiens)
- Amplification and expansion of oncogenic pathways as metastatic traits - WP3678 (Homo sapiens)
- Androgen receptor network in prostate cancer - WP2263 (Homo sapiens)
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP2864 (Homo sapiens)
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP3126 (Bos taurus)
- Arsenic liver toxicity pathway - WP5228 (Homo sapiens)
- Arsenic metabolism and reactive oxygen species generation - WP5233 (Homo sapiens)
- Artemisinin inhibition of uveal melanoma - WP5441 (Homo sapiens)
- Aryl hydrocarbon receptor - WP3226 (Bos taurus)
- Bladder cancer - WP2828 (Homo sapiens)
- Breast cancer pathway - WP4262 (Homo sapiens)
- CAMKK2 pathway - WP4874 (Homo sapiens)
- Cancer immunotherapy by CTLA4 blockade - WP4582 (Homo sapiens)
- Cancer immunotherapy by PD-1 blockade - WP4585 (Homo sapiens)
- Cancer pathways - WP5434 (Homo sapiens)
- Cell interactions of the pancreatic cancer microenvironment - WP5284 (Homo sapiens)
- Chromosomal and microsatellite instability in colorectal cancer - WP4216 (Homo sapiens)
- Clear cell renal cell carcinoma pathways - WP4018 (Homo sapiens)
- DNA IR-damage and cellular response via ATR - WP4016 (Homo sapiens)
- DNA IR-double strand breaks and cellular response via ATM - WP3959 (Homo sapiens)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP2291 (Homo sapiens)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP3171 (Bos taurus)
- Endometrial cancer - WP4155 (Homo sapiens)
- Epithelial to mesenchymal transition in colorectal cancer - WP4239 (Homo sapiens)
- ErbB signaling pathway - WP1261 (Mus musculus)
- ErbB signaling pathway - WP1299 (Rattus norvegicus)
- ErbB signaling pathway - WP673 (Homo sapiens)
- Extracellular vesicle-mediated signaling in recipient cells - WP2870 (Homo sapiens)
- Extracellular vesicle-mediated signaling in recipient cells - WP3161 (Bos taurus)
- FABP4 in ovarian cancer - WP4400 (Homo sapiens)
- FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma - WP4553 (Homo sapiens)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Fluoropyrimidine activity - WP3275 (Bos taurus)
- Folate-alcohol and cancer pathway hypotheses - WP1589 (Homo sapiens)
- Frustrated phagocytosis leading to malignant pleural mesothelioma - WP5091 (Homo sapiens)
- Gastric cancer network 1 - WP2361 (Homo sapiens)
- Gastric cancer network 1 - WP3166 (Bos taurus)
- Gastric cancer network 2 - WP2363 (Homo sapiens)
- Gastric cancer network 2 - WP3139 (Bos taurus)
- Genetic alterations of lung cancer - WP1968 (Rattus norvegicus)
- Glioblastoma signaling pathways - WP2261 (Homo sapiens)
- Glucose metabolism in triple-negative breast cancer cells - WP5211 (Homo sapiens)
- H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer - WP3969 (Homo sapiens)
- Head and neck squamous cell carcinoma - WP4674 (Homo sapiens)
- Hepatitis C and hepatocellular carcinoma - WP3646 (Homo sapiens)
- Hereditary leiomyomatosis and renal cell carcinoma pathway - WP4206 (Homo sapiens)
- Hippo signaling regulation pathways - WP4540 (Homo sapiens)
- Hormonal control of pubertal growth spurt - WP4194 (Homo sapiens)
- Imatinib and chronic myeloid leukemia - WP3640 (Homo sapiens)
- Immune infiltration in pancreatic cancer - WP5285 (Homo sapiens)
- Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells - WP4301 (Homo sapiens)
- Integrated cancer pathway - WP1971 (Homo sapiens)
- Integrated cancer pathway - WP3244 (Bos taurus)
- Interactions between LOXL4 and oxidative stress pathway - WP3670 (Homo sapiens)
- Interactions between immune cells and microRNAs in tumor microenvironment - WP4559 (Homo sapiens)
- Interactions of natural killer cells in pancreatic cancer - WP5092 (Homo sapiens)
- Irinotecan pathway - WP1080 (Bos taurus)
- Irinotecan pathway - WP124 (Rattus norvegicus)
- Irinotecan pathway - WP229 (Homo sapiens)
- Leukocyte-intrinsic Hippo pathway functions - WP4542 (Homo sapiens)
- MAPK pathway in congenital thyroid cancer - WP4928 (Homo sapiens)
- MET in type 1 papillary renal cell carcinoma - WP4205 (Homo sapiens)
- MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement - WP4560 (Homo sapiens)
- MFAP5-mediated ovarian cancer cell motility and invasiveness - WP3301 (Homo sapiens)
- Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms - WP4534 (Homo sapiens)
- Melanoma - WP4685 (Homo sapiens)
- Melatonin metabolism and effects - WP3298 (Homo sapiens)
- Metabolic reprogramming in colon cancer - WP4290 (Homo sapiens)
- Metabolic reprogramming in pancreatic cancer - WP5220 (Homo sapiens)
- Metastatic brain tumor - WP2249 (Homo sapiens)
- Metastatic brain tumor - WP3259 (Bos taurus)
- MicroRNA for targeting cancer growth and vascularization in glioblastoma - WP3593 (Homo sapiens)
- MicroRNA network associated with chronic lymphocytic leukemia - WP4399 (Homo sapiens)
- Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors - WP4397 (Homo sapiens)
- Modified nucleosides derived from tRNA as urinary cancer markers - WP4485 (Homo sapiens)
- NRP1-triggered signaling pathways in pancreatic cancer - WP5144 (Homo sapiens)
- Netrin-UNC5B signaling pathway - WP4747 (Homo sapiens)
- Neural crest cell migration in cancer - WP4565 (Homo sapiens)
- Neurogenesis regulation in the olfactory epithelium - WP5265 (Homo sapiens)
- Non-small cell lung cancer - WP4255 (Homo sapiens)
- PDGF pathway - WP2526 (Homo sapiens)
- PDGF pathway - WP3200 (Bos taurus)
- PDGFR-alpha and STMN1 cooperate to exacerbate cytotoxic effects of vinblastine - WP4398 (Mus musculus)
- PDGFR-beta pathway - WP3972 (Homo sapiens)
- PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer - WP3844 (Homo sapiens)
- PI3K-Akt signaling pathway - WP4172 (Homo sapiens)
- Pancreatic adenocarcinoma pathway - WP4263 (Homo sapiens)
- Pancreatic cancer subtypes - WP5390 (Homo sapiens)
- Pathways affected in adenoid cystic carcinoma - WP3651 (Homo sapiens)
- Photodynamic therapy-induced AP-1 survival signaling - WP3611 (Homo sapiens)
- Photodynamic therapy-induced HIF-1 survival signaling - WP3614 (Homo sapiens)
- Photodynamic therapy-induced NF-kB survival signaling - WP3617 (Homo sapiens)
- Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling - WP3612 (Homo sapiens)
- Photodynamic therapy-induced unfolded protein response - WP3613 (Homo sapiens)
- Physico-chemical features and toxicity-associated pathways - WP3680 (Homo sapiens)
- Pilocytic astrocytoma - WP2253 (Homo sapiens)
- Pleural mesothelioma - WP5087 (Homo sapiens)
- RAC1/PAK1/p38/MMP2 pathway - WP3303 (Homo sapiens)
- RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis - WP3873 (Homo sapiens)
- RalA downstream regulated genes - WP2290 (Homo sapiens)
- RalA downstream regulated genes - WP3268 (Bos taurus)
- Regulation of Wnt / B-catenin signaling by small molecule compounds - WP3664 (Homo sapiens)
- Regulation of apoptosis by parathyroid hormone-related protein - WP3872 (Homo sapiens)
- Retinoblastoma gene in cancer - WP2446 (Homo sapiens)
- Retinoblastoma gene in cancer - WP3206 (Bos taurus)
- Small cell lung cancer - WP4658 (Homo sapiens)
- Sulfatase and aromatase pathway - WP5368 (Homo sapiens)
- T cell modulation in pancreatic cancer - WP5078 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP3252 (Bos taurus)
- TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition - WP3859 (Homo sapiens)
- TP53 network - WP1742 (Homo sapiens)
- Tamoxifen metabolism - WP3264 (Bos taurus)
- Tamoxifen metabolism - WP691 (Homo sapiens)
- Toll-like receptor signaling related to MyD88 - WP3858 (Homo sapiens)
- Tumor suppressor activity of SMARCB1 - WP4204 (Homo sapiens)
- Type 2 papillary renal cell carcinoma - WP4241 (Homo sapiens)
- Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer - WP4284 (Homo sapiens)
- Warburg effect modulated by deubiquitinating enzymes and their substrates - WP5216 (Homo sapiens)
- Wnt/beta-catenin signaling pathway in leukemia - WP3658 (Homo sapiens)
- lncRNA in canonical Wnt signaling and colorectal cancer - WP4258 (Homo sapiens)
- lncRNA-mediated mechanisms of therapeutic resistance - WP3672 (Homo sapiens)
- miR-509-3p alteration of YAP1/ECM axis - WP3967 (Homo sapiens)
- miRNA regulation of p53 pathway in prostate cancer - WP3982 (Homo sapiens)
- miRNA regulation of prostate cancer signaling pathways - WP3981 (Homo sapiens)
- mir-193a and MVP in colon cancer metastasis - WP3979 (Mus musculus)
- ncRNAs involved in STAT3 signaling in hepatocellular carcinoma - WP4337 (Homo sapiens)
- ncRNAs involved in Wnt signaling in hepatocellular carcinoma - WP4336 (Homo sapiens)